Ceftazidime versus tobramycin-ticarcillin in the treatment of pneumonia and bacteremia.
A prospective, randomized study was undertaken to compare the efficacy and safety of ceftazidime with those of a combination of ticarcillin and tobramycin in the treatment of 40 nonneutropenic patients with pneumonia or bacteremia. Altogether, 93% of the patients receiving ceftazidime for pneumonia...
Сохранить в:
| Опубликовано в:: | Antimicrob Agents Chemother |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Society for Microbiology (ASM)
1985
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC176304/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3899005/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.28.1.33 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|